http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1267908-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17369e28baa208b320799cc7d72a8259 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0093 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-298 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-562 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C47-575 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C47-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 1986-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1990-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33749a6a607df3a54c355a1eb0941587 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30a719204bda96b7e9ce95ffe399dc8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b96112b9936eb6a6cb9a80bc9bc4a840 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3b3064e73541faf6e12b4e986fa97a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a2d0f113ffb24e3486b8fb459e585c4 |
| publicationDate | 1990-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1267908-A |
| titleOfInvention | Tumor-inhibiting (1,2-diphenyl-ethylene-diamine)- platinum (ii) complexes |
| abstract | ABSTRACT OF THE DISCLOSURE Antitumor-active (1,2-diphenyl-ethylene-diamine)-platinum (II) complexes having the general formula I wherein R7 represents hydrogen or C1-C6 alkyl and R2 either represents a halogen atom and the radicals R1, R3, R4, R5 and R6 are identical or different and represent hydrogen, halogen, tri-halomethyl, C1-C6 alkyl, hydroxy, C1-C6 alkoxy or a C2-C6 alkanoyl-oxy group substituted, when required, by halogen or C1-C4-alkane-sulphonyloxy or wherein R2 represents a hydroxy group, a C1-C6 alkoxy group, a C2-C6 alkanoyl-oxy group in the 4-position which may be substituted by halogen or C1-C4 alkane sulphonyl oxy and in this case the radicals R1 and R3, which are identical or different, are in the 2- and 6-position of the phenyl radical and represent halogen, trihalomethyl, C1-C6 alkyl, hydroxy, C1-C6 alkoxy or an alkanoyl-oxy group substituted, when required, by halogen or C1-C4 alkane sul-phonyloxy, and in case that R3 represents halogen, trihalo-methyl or C1-C6 alkyl R1 can also represent hydrogen and the radicals R4, R5 and R6 are identical or different and repre-sent hydrogen, halogen, trihalomethyl, C1-C6 alkyl, hydroxy, C1-C6 alkoxy or a C2-C6 alkanoyl-oxy group substituted, when required, by halogen or C1-C4 alkane sulphonyl oxy, and X represents the equivalent of a physiologically compatible anion. |
| priorityDate | 1985-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 152.